Published in J Biol Chem on November 15, 2004
Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am J Physiol Cell Physiol (2009) 1.72
The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell (2005) 1.49
Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis. PLoS Genet (2015) 1.38
Alveolar epithelial type II cells activate alveolar macrophages and mitigate P. Aeruginosa infection. PLoS One (2009) 1.31
Elevated inflammatory response in caveolin-1-deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF-kappaB). J Biol Chem (2011) 1.31
Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells. Infect Immun (2005) 1.30
Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun (2007) 1.30
RNAi screen reveals an Abl kinase-dependent host cell pathway involved in Pseudomonas aeruginosa internalization. PLoS Pathog (2008) 1.20
Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol (2014) 1.09
Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa. J Biol Chem (2009) 1.02
Autophagy enhances bacterial clearance during P. aeruginosa lung infection. PLoS One (2013) 0.96
Caveolin-1 modifies the immunity to Pseudomonas aeruginosa. J Immunol (2009) 0.95
Caveolin-1 plays a critical role in host immunity against Klebsiella pneumoniae by regulating STAT5 and Akt activity. Eur J Immunol (2012) 0.92
Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts. Am J Physiol Cell Physiol (2009) 0.92
Novel insights into the role of caveolin-2 in cell- and tissue-specific signaling and function. Biochem Res Int (2011) 0.92
Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-β in endothelial cells. Am J Physiol Cell Physiol (2011) 0.92
Transcription analysis on response of porcine alveolar macrophages to Haemophilus parasuis. BMC Genomics (2012) 0.84
Caveolins and lung function. Adv Exp Med Biol (2012) 0.84
Hijacking the endocytic machinery by microbial pathogens. Protoplasma (2010) 0.84
Virulence and resistance features of Pseudomonas aeruginosa strains isolated from chronic leg ulcers. BMC Infect Dis (2016) 0.83
Glycolipid-Dependent, Protease Sensitive Internalization of Pseudomonas aeruginosa Into Cultured Human Respiratory Epithelial Cells. Open Microbiol J (2010) 0.83
The expanding roles of caveolin proteins in microbial pathogenesis. Commun Integr Biol (2009) 0.83
The role of lipid raft aggregation in the infection of type II pneumocytes by Mycobacterium tuberculosis. PLoS One (2012) 0.78
Role of Caveolin Proteins in Sepsis. Pediatr Ther (2012) 0.75
The virulence factor ychO has a pleiotropic action in an Avian Pathogenic Escherichia coli (APEC) strain. BMC Microbiol (2016) 0.75
A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78
Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature (2005) 5.11
The genetic landscape of mutations in Burkitt lymphoma. Nat Genet (2012) 3.03
Topological structure analysis of the protein-protein interaction network in budding yeast. Nucleic Acids Res (2003) 2.90
Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med (2007) 2.72
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol (2003) 2.68
Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med (2008) 2.27
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot Cell (2006) 1.92
Concern c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice. Am J Respir Crit Care Med (2011) 1.91
Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity (2013) 1.80
Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem (2004) 1.72
Spores as infectious propagules of Cryptococcus neoformans. Infect Immun (2009) 1.72
Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol (2009) 1.69
Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury. Am J Respir Crit Care Med (2011) 1.66
Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc (2007) 1.65
Attenuated virulence of a Francisella mutant lacking the lipid A 4'-phosphatase. Proc Natl Acad Sci U S A (2007) 1.64
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
Microbial entry through caveolae: variations on a theme. Cell Microbiol (2002) 1.44
Retracted Nitric oxide mediates relative airway hyporesponsiveness to lipopolysaccharide in surfactant protein A-deficient mice. Am J Respir Cell Mol Biol (2010) 1.44
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog (2007) 1.41
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 1.40
TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci U S A (2009) 1.38
Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol (2002) 1.30
Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol (2003) 1.28
The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta (2005) 1.23
The distinct binding specificities exhibited by enterobacterial type 1 fimbriae are determined by their fimbrial shafts. J Biol Chem (2005) 1.20
Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem (2004) 1.19
Innate immunity and its regulation by mast cells. J Immunol (2013) 1.19
Mast cell modulation of the vascular and lymphatic endothelium. Blood (2011) 1.19
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe (2009) 1.17
Complement levels and activity in the normal and LPS-injured lung. Am J Physiol Lung Cell Mol Physiol (2006) 1.15
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater (2012) 1.12
Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol Lett (2004) 1.10
Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife (2013) 1.10
Alveolar epithelial type II cells induce T cell tolerance to specific antigen. J Immunol (2008) 1.10
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. Vaccine (2009) 1.09
The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol (2002) 1.06
Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol (2004) 1.06
Pulmonary surfactant proteins A and D directly suppress CD3+/CD4+ cell function: evidence for two shared mechanisms. J Immunol (2002) 1.05
Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. Am J Physiol Lung Cell Mol Physiol (2003) 1.04
Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect Immun (2009) 1.04
Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol (2003) 1.04
Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa. J Biol Chem (2009) 1.02
Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata. G3 (Bethesda) (2012) 1.02
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines. Nat Med (2009) 0.99
Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS One (2010) 0.99
Surfactant protein A is defective in abrogating inflammation in asthma. Am J Physiol Lung Cell Mol Physiol (2011) 0.98
Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules. Am J Physiol Lung Cell Mol Physiol (2004) 0.98
The role of surfactant protein A in bleomycin-induced acute lung injury. Am J Respir Crit Care Med (2010) 0.94
Surfactant protein A enhances apoptotic cell uptake and TGF-beta1 release by inflammatory alveolar macrophages. Am J Physiol Lung Cell Mol Physiol (2003) 0.94
Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1. J Immunol (2009) 0.93
Bacterial penetration of the mucosal barrier by targeting lipid rafts. J Investig Med (2005) 0.92
SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice. J Immunol (2009) 0.92
Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms. PLoS One (2007) 0.92
Intestinal mast cells mediate gut injury and systemic inflammation in a rat model of deep hypothermic circulatory arrest. Crit Care Med (2013) 0.91
Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. J Clin Invest (2011) 0.91
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits. PLoS One (2011) 0.91
Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat Rev Microbiol (2013) 0.91
TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes. Am J Physiol Lung Cell Mol Physiol (2006) 0.91
Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol (2006) 0.91
The mast cell in innate and adaptive immunity. Adv Exp Med Biol (2011) 0.89
Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis. J Immunol (2006) 0.89
Surfactant protein A differentially regulates peripheral and inflammatory neutrophil chemotaxis. Am J Physiol Lung Cell Mol Physiol (2002) 0.88
Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis. J Biol Chem (2012) 0.87
Stable dry powder formulation for nasal delivery of anthrax vaccine. J Pharm Sci (2011) 0.86
Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro. Am J Respir Cell Mol Biol (2004) 0.86
Surfactant protein-A (SP-A) selectively inhibits prostaglandin F2alpha (PGF2alpha) production in term decidua: implications for the onset of labor. J Clin Endocrinol Metab (2011) 0.85
Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes. Am J Physiol Lung Cell Mol Physiol (2006) 0.85
Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol (2011) 0.85
Surfactant protein D decreases pollen-induced IgE-dependent mast cell degranulation. Am J Physiol Lung Cell Mol Physiol (2005) 0.85
Involvement of dynamin-2 in formation of discoid vesicles in urinary bladder umbrella cells. Cell Tissue Res (2009) 0.85
Surfactant protein A modulates induction of regulatory T cells via TGF-β. J Immunol (2012) 0.84
Clearance of surfactant lipids by neutrophils and macrophages isolated from the acutely inflamed lung. Am J Physiol Lung Cell Mol Physiol (2002) 0.83
New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr Opin Immunol (2009) 0.83
The expanding roles of caveolin proteins in microbial pathogenesis. Commun Integr Biol (2009) 0.83
Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis. Infect Immun (2013) 0.82
Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice. Dis Model Mech (2013) 0.82
New roles for mast cells in pathogen defense and allergic disease. Discov Med (2010) 0.81
Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo. Am J Physiol Lung Cell Mol Physiol (2002) 0.81
Surfactant protein-A suppresses eosinophil-mediated killing of Mycoplasma pneumoniae in allergic lungs. PLoS One (2012) 0.81
Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation. J Immunol (2011) 0.81
A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. Vaccine (2013) 0.81
In vivo clearance of surfactant lipids during acute pulmonary inflammation. Respir Res (2004) 0.80
Surfactant protein-A inhibits mycoplasma-induced dendritic cell maturation through regulation of HMGB-1 cytokine activity. J Immunol (2010) 0.80
Review: Collectins link innate and adaptive immunity in allergic airway disease. Innate Immun (2010) 0.79
SHP-1 as a critical regulator of Mycoplasma pneumoniae-induced inflammation in human asthmatic airway epithelial cells. J Immunol (2012) 0.79